Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

1.3K
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
1.3K
SBAR II: Application of SBAR01:14

SBAR II: Application of SBAR

6.8K
SBAR is an effective communication tool used by healthcare professionals to communicate patient information accurately. SBAR stands for Situation, Background, Assessment, and Recommendation. For a better understanding, an example is given below.
SBAR Report from a Nurse to a Health Care Provider
S: "Hello, Dr. Smith. This is Jane, RN, from the Med Surg unit. I am calling to tell you about Ms. White in Room 210, who is experiencing increased pain and redness at her incision site. Her recent...
6.8K
Oral Hypoglycemic Agents: Glinides01:06

Oral Hypoglycemic Agents: Glinides

961
Repaglinide (Prandin) and Nateglinide (Starlix), known as glinides, are oral insulin secretagogues that stimulate insulin release from pancreatic β cells by closing the ATP-sensitive potassium channels (KATP channel). Repaglinide controls insulin release from pancreatic β cells by managing potassium efflux. It shares two binding sites with sulfonylureas and also has a unique site, indicating overlapping mechanisms of action. With a rapid onset and a 4-7 hour duration, it effectively...
961
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

5.6K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
5.6K
Pulse rhythm01:30

Pulse rhythm

1.6K
Pulse rhythm refers to the pattern of pulsations within specific intervals, offering valuable insights into the regularity or irregularity of the heart's beats as observed through the pattern of pulsation within specific intervals. A regular pulse exhibits a consistent heart rate with uniform waveforms and pulsation force, variations of which can be classified as normal, weak, or bounding.
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac...
1.6K
Dipeptidyl Peptidase 4 Inhibitors01:23

Dipeptidyl Peptidase 4 Inhibitors

1.1K
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
1.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Influence of plasma screening on high-density inverse bremsstrahlung absorption.

Physical review. E·2025
Same author

Inverse bremsstrahlung absorption rate for super-Gaussian electron distribution functions including plasma screening.

Physical review. E·2024
Same author

Screening for undiagnosed pancreatic exocrine insufficiency (PEI) in a cohort of diabetic patients using faecal elastase testing and PEI scoring system.

Acta diabetologica·2024
Same author

Structures of strong shocks in low-density helium and neon gases.

Physical review. E·2023
Same author

Hyponatraemia and the syndrome of inappropriate antidiuresis (SIAD) in cancer.

Endocrine oncology (Bristol, England)·2023
Same author

Editorial: Adrenal insufficiency: Diagnostic approaches, treatments and outcomes.

Frontiers in endocrinology·2023
Same journal

Causal Association Between Thyroid Function and Myeloproliferative Disease: A Two-Sample Mendelian Randomization Study.

International journal of endocrinology·2026
Same journal

The Role of Lipid Disorders in Cardiovascular Mortality Among Saudis: A Review Perspective.

International journal of endocrinology·2026
Same journal

A Novel Sarcopenia Screening Score Based on Thyroid Function Parameters in Euthyroid Middle-Aged and Elderly Chinese Adults.

International journal of endocrinology·2026
Same journal

Repurposing the Antibiotic Tigecycline to Inhibit Tumor Growth and Hormone Secretion in Somatotroph Pituitary Neuroendocrine Tumors.

International journal of endocrinology·2026
Same journal

Deletion of miR-122-5p Exacerbated Hyperthyroidism-Induced Liver Injury by Regulating Ferroptosis.

International journal of endocrinology·2026
Same journal

RETRACTION: Antidiabetic Activity of <i>Vinca rosea</i> Extracts in Alloxan-Induced Diabetic Rats.

International journal of endocrinology·2026
See all related articles

Related Experiment Video

Updated: Apr 5, 2026

Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

19.5K

Addressing Inpatient Glycaemic Control with an Inpatient Glucometry Alert System.

J N Seheult1, A Pazderska2, P Gaffney1

  • 1Clinical Chemistry Department, Adelaide and Meath Hospital, Tallaght, Dublin 24, Ireland.

International Journal of Endocrinology
|August 21, 2015
PubMed
Summary
This summary is machine-generated.

An alert system significantly reduced hyperglycemia in hospitalized patients by processing blood glucose results. This improved patient care by decreasing high blood glucose levels and speeding up normalization.

More Related Videos

Simple Continuous Glucose Monitoring in Freely Moving Mice
03:25

Simple Continuous Glucose Monitoring in Freely Moving Mice

Published on: February 24, 2023

8.7K
Studying the Hypothalamic Insulin Signal to Peripheral Glucose Intolerance with a Continuous Drug Infusion System into the Mouse Brain
08:32

Studying the Hypothalamic Insulin Signal to Peripheral Glucose Intolerance with a Continuous Drug Infusion System into the Mouse Brain

Published on: January 4, 2018

11.0K

Related Experiment Videos

Last Updated: Apr 5, 2026

Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

19.5K
Simple Continuous Glucose Monitoring in Freely Moving Mice
03:25

Simple Continuous Glucose Monitoring in Freely Moving Mice

Published on: February 24, 2023

8.7K
Studying the Hypothalamic Insulin Signal to Peripheral Glucose Intolerance with a Continuous Drug Infusion System into the Mouse Brain
08:32

Studying the Hypothalamic Insulin Signal to Peripheral Glucose Intolerance with a Continuous Drug Infusion System into the Mouse Brain

Published on: January 4, 2018

11.0K

Area of Science:

  • Clinical Medicine
  • Health Informatics

Background:

  • Poor inpatient glycaemic control affects over 30% of patients.
  • Suboptimal glucose management leads to longer hospital stays, increased complications, and mortality.

Purpose of the Study:

  • To enhance inpatient glycaemic control.
  • To develop an automated alert system for point-of-care blood glucose (POC-BG) results.

Main Methods:

  • Developed Microsoft Excel Macros to process daily glucometry data.
  • Generated alerts for hypoglycemia (<4 mmol/L) and hyperglycemia (>15 mmol/L).
  • Implemented a 60-day system with weekday Diabetes Team consultations.

Main Results:

  • Achieved a 20% reduction in hyperglycemic patient-day weighted values (>15 mmol/L).
  • Reduced time-to-next-reading after dysglycemic results by 14%.
  • Decreased time-to-normalization of dysglycemic results from 10.2 to 8.4 hours.

Conclusions:

  • The alert system effectively reduced hyperglycemia in hospitalized patients.
  • The system improved the timeliness of glucose level normalization.